Implementation of Enhanced Recovery After Surgery Program (ERAS) in Colorectal Cancer Surgery, a Randomized Controlled Trial
Primary Purpose
Cancer of Colon
Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
enhanced recovery after surgery program in colorectal cancer surgery
Sponsored by
About this trial
This is an interventional health services research trial for Cancer of Colon
Eligibility Criteria
Inclusion Criteria:
- Age ≤ 60 years,
- Good nutrition,
- No systemic infection and
- Elective laparoscopic surgery
Exclusion Criteria:
- Age >75 years,
- Malnutrition or an organ system infection
- Associated with obstruction, bleeding, emergency surgery or other surgical intervention
- Tumor with extensive metastasis
- Prior to surgery, patient was fasting, underwent gastrointestinal decompression and received nutritional support
- Previous history of abdominal surgery
- Patient have previously undergone gastrostomy
Sites / Locations
- South Egypt Cancer Instuite
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
thefast track (FTS group)
Thecontrolgroup
Arm Description
Outcomes
Primary Outcome Measures
length of hospital stay in days
length of hospital stay in days
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03928678
Brief Title
Implementation of Enhanced Recovery After Surgery Program (ERAS) in Colorectal Cancer Surgery, a Randomized Controlled Trial
Official Title
Enhanced Recovery After Surgery Program (ERAS) in Colorectal Cancer Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
May 1, 2019 (Actual)
Primary Completion Date
November 1, 2020 (Actual)
Study Completion Date
December 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The aim of our study is to determine the effect of implementation of the ERAS (enhanced recovery after surgery) protocol in our institute and its impact on hospital length of stay and outcome of surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer of Colon
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
thefast track (FTS group)
Arm Type
Active Comparator
Arm Title
Thecontrolgroup
Arm Type
Placebo Comparator
Intervention Type
Procedure
Intervention Name(s)
enhanced recovery after surgery program in colorectal cancer surgery
Intervention Description
to determine the feasibility of implementation of the ERAS protocol in our institute and its impact on hospital length of stay and outcome of surgery.
Primary Outcome Measure Information:
Title
length of hospital stay in days
Description
length of hospital stay in days
Time Frame
4 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age ≤ 60 years,
Good nutrition,
No systemic infection and
Elective laparoscopic surgery
Exclusion Criteria:
Age >75 years,
Malnutrition or an organ system infection
Associated with obstruction, bleeding, emergency surgery or other surgical intervention
Tumor with extensive metastasis
Prior to surgery, patient was fasting, underwent gastrointestinal decompression and received nutritional support
Previous history of abdominal surgery
Patient have previously undergone gastrostomy
Facility Information:
Facility Name
South Egypt Cancer Instuite
City
Assuit
ZIP/Postal Code
171516
Country
Egypt
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Implementation of Enhanced Recovery After Surgery Program (ERAS) in Colorectal Cancer Surgery, a Randomized Controlled Trial
We'll reach out to this number within 24 hrs